LONDON (Reuters) - Philip Morris International (NYSE: PM) began selling its IQOS heated tobacco device in Austin, Texas on ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.